Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2008
11/11/2008US7449482 Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
11/11/2008US7449470 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/06/2008WO2008134630A1 Dexrazoxane compounds for cardioprotection
11/06/2008WO2008134602A1 Levosimendan dosage regimen
11/06/2008WO2008134547A1 Methods of using hydroxycyclohexane and hydroxypiperidine compounds in treating sodium channel-mediated diseases or conditions
11/06/2008WO2008134445A2 Platelet activation receptor clec-2: compositions and uses thereof
11/06/2008WO2008133949A1 Analogues of cilostazol
11/06/2008WO2008133896A2 Dual-acting antihypertensive agents
11/06/2008WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008133141A1 Osmotin recombinant protein, method for production of the same, and use of the same
11/06/2008WO2008132846A1 Tricyclic heteroaryl compound
11/06/2008WO2008132729A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008WO2008132712A2 Combination pharmaceutical compositions
11/06/2008WO2008132710A2 Pharmaceutical nimodipine compositions
11/06/2008WO2008132679A1 Bridged six-membered ring compounds
11/06/2008WO2008132453A1 Antibodies against ramp3
11/06/2008WO2008132239A1 Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
11/06/2008WO2008132025A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008131859A2 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008WO2008131858A2 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008WO2008104975A3 Combination therapy, composition and methods for the treatment of cardiovascular disorders
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008089103A3 Targeting ncca-atp channel for organ protection following ischemic episode
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008WO2008073395A3 Compositions and methods for cardiac tissue protection and regeneration
11/06/2008WO2008072190A3 Compositions of azimilide dihydrochloride
11/06/2008WO2008057802A3 Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
11/06/2008WO2007127475A3 Pyridazines for demyelinating diseases and neuropathic pain
11/06/2008US20080275238 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction; diabetes
11/06/2008US20080275136 Use of Glycerol for Improving Cardiac Function
11/06/2008US20080275135 Resorcinol Derivatives and Their Use for Lowering Blood Pressure
11/06/2008US20080275105 Thienyl-acylhydrazone derivatives; muscular disorders; antiischemic, hypotensive, and antispasmodic agents; cardiovascular and respiratory system disorders
11/06/2008US20080275102 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275082 Comprising NK3 receptor antagonist talnetant, povidone, erythritol and Sodium Lauryl Sulfate; erythritol used as soluble filler in preparation of stable drug; dosage tablet or capsule
11/06/2008US20080275075 Medicine Comprising a Combination of an Acetylcholinesterase Inhibitor and a 5-Substituted-3-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275068 Method of Using Vasoconstrictive Agents During Energy-Based Tissue Therapy
11/06/2008US20080275064 N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-2-piperidin-1-yl-acetamide; antiischemic agents, antidiabetics; autoimmune diseases, Asthma, Obesity, Huntington's Disease, Dystonia, Dyskinesias, Parkinson's Disease, Inflammatory Bowl Disease
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275059 Novel physiologically active substances
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275049 Methods and Compositions for Upregulation of GATA Activity
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275036 Prevention and treatment of cardiac conditions
11/06/2008US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275020 Pharmaceutical formulation
11/06/2008US20080275011 Synergistic mixture; mycardial infraction; cardiovascular disorders
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080275007 Charged phospholipid compositions and methods for their use
11/06/2008US20080274994 Dna sequence and genomic structure of human cardiac isoform; gene or allele mutants associated with cardiovascular disorders; reduce stretch activation and adjust tension of muscles in heart contraction; isolated nucleic acid encoding a protein
11/06/2008US20080274977 Treating stroke and other diseases without inhibiting N-type calcium channels
11/06/2008US20080274976 Uses of novel potassium channel blockers
11/06/2008US20080274970 Vascular adhesion molecules and modulation of their function
11/06/2008US20080274947 Antilipemic agents; metabolic disorders; insulin resistance; antidiabetic agents
11/06/2008US20080274945 Infant Nutrition With Protease Inhibitor
11/06/2008US20080274193 Retinoic Acid-Containing Antidiabetic Agent
11/06/2008US20080274171 Renin Inhibitors Nitroderivatives
11/06/2008US20080274170 Peptide epitopes of apolipoprotein b
11/06/2008US20080274116 Lipids, Lipid Complexes and Use Thereof
11/06/2008US20080274096 Fusion Proteins Having a Modulated Half-Life in Plasma
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008DE102007020378A1 Agent with natural nitrate content and health promoting effect, which in the consumption by humans or animals with an effect of e.g. increasing the nitrate and nitrite content in the blood or increasing the flow-mediated dilatation
11/06/2008CA2685593A1 Combination pharmaceutical compositions
11/06/2008CA2685591A1 Pharmaceutical nimodipine compositions
11/06/2008CA2685534A1 Use of matrix metalloproteinase inhibitors in skin care
11/06/2008CA2685446A1 Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
11/06/2008CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008CA2685134A1 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008CA2685128A1 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008CA2685099A1 Antibodies against ramp3
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/06/2008CA2683488A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008CA2682508A1 Dual-acting antihypertensive agents
11/06/2008CA2679658A1 Fusion proteins binding to growth factors
11/06/2008CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1988090A1 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
11/05/2008EP1987829A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
11/05/2008EP1987828A1 salts of perindopril and their use in the therapy of hypertension
11/05/2008EP1987824A1 Composition for normalizing blood pressure
11/05/2008EP1987064A1 Domain antibody construct
11/05/2008EP1987005A2 New pyridin-3-amine derivatives
11/05/2008EP1987004A2 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
11/05/2008EP1986644A1 Drug combinations for the treatment of respiratory tract diseases
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
1 ... 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 ... 1595